Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 6;295(10):3371-3384.
doi: 10.1074/jbc.X120.012838.

Sphingosine-1-phosphate: From insipid lipid to a key regulator

Affiliations

Sphingosine-1-phosphate: From insipid lipid to a key regulator

Sarah Spiegel. J Biol Chem. .

Abstract

It is a great honor to be asked to write a "Reflections" article by one of the true icons of biochemistry, Herb Tabor. I felt humbled, especially since it follows many written by biochemists I admire and whose contributions have shaped major advances in biochemistry and molecular biology in the last century. Here I present my personal reflections on my adventure with the bioactive sphingolipid metabolite sphingosine-1-phosphate intertwined with those of my family life as a wife, mother, and grandmother. These reflections brought back many memories of events in my early career that played significant roles in determining the path I have taken for more than 40 years and that brought much fun and satisfaction into my life. It has been an exciting journey so far, with many surprises along the way, that still continues.

Keywords: S1PR; sphingolipid; sphingolipid metabolites; sphingosine 1-phosphate (S1P); sphingosine kinase (SphK).

PubMed Disclaimer

Conflict of interest statement

The author declares that she has no conflicts of interest with the contents of this article

Figures

Figure 1.
Figure 1.
A, Professor Meir Wilchek and me working on my first paper. B, my children Shlomit and Michael when we arrived in a new country and I started as a postdoc at NIH in Bethesda.
Figure 2.
Figure 2.
Finding gold in a dirt (shmutz) pile. A and B, identification of the first schmutz S1P, produced by phosphorylation of sphingosine as a novel lipid involved in cellular proliferation. Taken from Ref. . This research was originally published in the Journal of Cell Biology. Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., and Spiegel, S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 1991; 114:155–167. © Rockefeller University Press. C, 600,000-fold purification of SphK1 and isolation of a 49-kDa SphK1 polypeptide.
Figure 3.
Figure 3.
Professor Sen-itiroh Hakomori and me at a meeting.
Figure 4.
Figure 4.
Walter Shaw, President of Avanti Polar Lipids, presenting the ASBMB Avanti Award in Lipids to Sarah Spiegel in New Orleans in April 2009. Dr. Al Merrill (right), session chair, nominated Sarah Spiegel for the award.
Figure 5.
Figure 5.
Photos of attendees at the Gordon Research Conferences on Glycolipid and Sphingolipid Biology (Ventura, CA) in 1998 (top) and in 2014 (bottom).
Figure 6.
Figure 6.
S1P: The blind men and the elephant. Reproduced from (83) with permission from Elsevier.
Figure 7.
Figure 7.
Virginia's Outstanding Scientist of 2008 ceremony in the Science Museum (Richmond, VA). A, VCU leadership (from left to right): Dr. Jerome Strauss, Dean of the School of Medicine; Dr. Sheldon Retchin, VP for Health Sciences; Dr. Sarah Spiegel; Dr. Frank Macrina, VP for Research and Innovation; Dr. Gordon Ginder, Director of the Massey Cancer Center. B, Dr. Spiegel and the Governor of Virginia, Tim Kaine. C, my family (from left to right): Dr. Shlomit Spiegel Mittler, Dr. Sarah Spiegel, Dr. Sheldon Milstien, Ben Milstien, Sarah Milstien Kennard, Annika Milstien, Fred Kennard, Dr. Michael Spiegel, Liraz Arazi, Oren Arazi, Shula Arazi, Yossi Arazi.
Figure 8.
Figure 8.
Our research group at VCU in 2008. Shown (from left to right) are Dr. Dai Shida, Dr. Nitai Hait, Poulami Mitra, Dr. Carol Oskeritzian, Dr. Sheldon Milstien, Dr. Sarah Spiegel, Graham Strub, Megan Price, Dr. Sergio Alvarez, Steve Paugh, Dr. Sandrine Lepine, Dr. Michael Maceyka, Dr. Kazuaki Takabe, and Dr. Dmitri Kapitonov.

References

    1. Spiegel S., Ravid A., and Wilchek M. (1979) Involvement of gangliosides in lymphocyte stimulation. Proc. Natl. Acad. Sci. U.S.A. 76, 5277–5281 10.1073/pnas.76.10.5277 - DOI - PMC - PubMed
    1. Spiegel S., Schlessinger J., and Fishman P. H. (1984) Incorporation of fluorescent gangliosides into human fibroblasts: mobility, fate, and interaction with fibronectin. J. Cell Biol. 99, 699–704 10.1083/jcb.99.2.699 - DOI - PMC - PubMed
    1. Barton N. W., Furbish F. S., Murray G. J., Garfield M., and Brady R. O. (1990) Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc. Natl. Acad. Sci. U.S.A. 87, 1913–1916 10.1073/pnas.87.5.1913 - DOI - PMC - PubMed
    1. Spiegel S., Kassis S., Wilchek M., and Fishman P. H. (1984) Direct visualization of redistribution and capping of fluorescent gangliosides on lymphocytes. J. Cell Biol. 99, 1575–1581 10.1083/jcb.99.5.1575 - DOI - PMC - PubMed
    1. Spiegel S., Yamada K. M., Hom B. E., Moss J., and Fishman P. H. (1985) Fluorescent gangliosides as probes for the retention and organization of fibronectin by ganglioside-deficient mouse cells. J. Cell Biol. 100, 721–726 10.1083/jcb.100.3.721 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources